| Dr Kris Frankenberg, DC | |
|
5172 Mcginnis Ferry Rd, Alpharetta, GA 30005-1792 | |
| (678) 624-0000 | |
| (678) 624-0002 |
| Full Name | Dr Kris Frankenberg |
|---|---|
| Gender | Male |
| Speciality | Chiropractor |
| Location | 5172 Mcginnis Ferry Rd, Alpharetta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194800730 | NPI | - | NPPES |
| 52165356001 | Other | GA | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | CHIR006744 (Georgia) | Primary |
| Provider Name | Virgil Bryant Management |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1609186626 PECOS PAC ID: 2860675444 Enrollment ID: O20110318000452 |
News Archive
Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation credit line of approximately € 3 million from Agentschap NL, an agency of the Dutch Ministry of Economic Affairs. Mucosis will use this loan towards the clinical development of its lead product FluGEM™, an influenza vaccine that can be administered by a simple spray in the nose. The loan will be redeemed only if the FluGEM™ clinical development program is concluded successfully.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.
Kimball Electronics Group, a subsidiary of Kimball International, Inc., has added Katie Eggert and Anita Conlin to the Business Development Team focused on growth of the Company's medical sector.
Elan plc and Boehringer Ingelheim today announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics.
› Verified 6 days ago
| Provider Name | Clark Integrated Medical Clinics Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1124529284 PECOS PAC ID: 8022372598 Enrollment ID: O20180509000736 |
News Archive
Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation credit line of approximately € 3 million from Agentschap NL, an agency of the Dutch Ministry of Economic Affairs. Mucosis will use this loan towards the clinical development of its lead product FluGEM™, an influenza vaccine that can be administered by a simple spray in the nose. The loan will be redeemed only if the FluGEM™ clinical development program is concluded successfully.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.
Kimball Electronics Group, a subsidiary of Kimball International, Inc., has added Katie Eggert and Anita Conlin to the Business Development Team focused on growth of the Company's medical sector.
Elan plc and Boehringer Ingelheim today announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kris Frankenberg, DC 5172 Mcginnis Ferry Rd, Alpharetta, GA 30005-1792 Ph: (678) 624-0000 | Dr Kris Frankenberg, DC 5172 Mcginnis Ferry Rd, Alpharetta, GA 30005-1792 Ph: (678) 624-0000 |
News Archive
Dutch vaccine development company Mucosis B.V. announced today that it has received an innovation credit line of approximately € 3 million from Agentschap NL, an agency of the Dutch Ministry of Economic Affairs. Mucosis will use this loan towards the clinical development of its lead product FluGEM™, an influenza vaccine that can be administered by a simple spray in the nose. The loan will be redeemed only if the FluGEM™ clinical development program is concluded successfully.
Medunik Canada, a Canadian pharmaceutical company specialized in rare diseases, is pleased to announce that PHEBURANE (a tasteless oral formulation of sodium phenylbutyrate), is now available for distribution in Canada. PHEBURANE is the first drug to be approved in Canada for the chronic management of urea cycle disorders (UCD) after receiving market authorisation on January 27th, 2015.
CombinatoRx, Incorporated, today announced that its ophthalmic collaborator, Fovea Pharmaceuticals SA, has entered into a proposed acquisition with Sanofi-Aventis. A CombinatoRx-derived combination drug candidate, Prednisporin, (FOV1101), which is a fixed dose combination of prednisolone and cyclosporine, is the most advanced product asset in the Fovea pipeline, with Phase 2b clinical studies planned for the treatment of persistent allergic conjunctivitis.
Kimball Electronics Group, a subsidiary of Kimball International, Inc., has added Katie Eggert and Anita Conlin to the Business Development Team focused on growth of the Company's medical sector.
Elan plc and Boehringer Ingelheim today announced that they have entered into a global technical development and manufacturing agreement for antibody-based therapeutics.
› Verified 6 days ago
North Point Family Chiropractic Center Chiropractor Medicare: Medicare Enrolled Practice Location: 3180 N Point Pkwy Ste 101, Alpharetta, GA 30005 Phone: 770-993-4464 Fax: 770-993-4221 | |
Dr. Anthony Edward Meade, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7431 N Point Pkwy, Suite 1320, Alpharetta, GA 30022 Phone: 678-298-2080 | |
Dr. Matthew A Graves, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 6110 Mcfarland Station Dr Ste 400, Alpharetta, GA 30004 Phone: 770-851-9890 | |
Dr. Kyle Soles, DC Chiropractor Medicare: Medicare Enrolled Practice Location: 6495 Shiloh Rd, Alpharetta, GA 30005 Phone: 770-740-9200 | |
Levinson Family Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 9950 Jones Bridge Rd, Alpharetta, GA 30022 Phone: 770-754-0037 Fax: 770-754-7828 | |
Ms. Deborah Pearson Garcia, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 8470 Holcomb Bridge Rd, Suite 150, Alpharetta, GA 30022 Phone: 770-993-3200 Fax: 770-641-8017 | |
Dr. Shannan Christine Starman, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 11535 Park Woods Cir, Suite D, Alpharetta, GA 30005 Phone: 770-521-1114 Fax: 770-521-1194 |